Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Treatment Preferences for Subcutaneous Immunoglobulin Among Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Caregivers, and Physicians: A Discrete Choice Experiment.
Adrenal gland dysfunction in males with cluster headache.
Corrigendum to "Treatment discontinuation in older patients with multiple sclerosis" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106741].
PHGDH-mediated serine synthesis reduces oligodendrocyte death by sustaining GSH and NADPH levels after brain ischemia.
Dual role of Ninjurin-1 in myeloid cell adhesion and inflammation in relapse-remitting EAE.
Spleen-brain axis regulates myelin integrity via TGF-β1 signaling in cuprizone-induced demyelination and remyelination model.
Fatal Case of Balamuthia Amoebic Encephalitis in a Patient With MOG Antibody-Associated Disease.
Pharmacovigilance signal detection of central nervous system demyelinating diseases following human papillomavirus vaccination: data mining and signal analysis based on the VAERS database.
[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].
Safety and Effectiveness of Inebilizumab in Patients with Neuromyelitis Optica Spectrum Disorder: Interim Analysis of a Post-marketing Surveillance in Japan.
Multiple sclerosis in Colombia: nationwide surveillance-based estimates and trends, 2016-2024.
Sustained Delivery of Exosome-Encapsulated Ellagic Acid via Injectable Self-Healing Hydrogel for Spinal Cord Injury Repair.
Evaluating the neurofilament light chain-derived gap between biological and chronological age in multiple sclerosis and controls.
Plumbagin ameliorates multiple sclerosis by inducing DDX3X-mediated stress granule assembly in mice.
CD11c+ CD8 T cells cause IFN-γ-dependent autoimmune neuroinflammation that is restrained by PD-1 signaling.
A voyage on computer aided intelligent algorithms for the segmentation of brain tissues for neurodisorder diagnosis.
ALDH2 deficiency exacerbates acrolein-mediated neuropathology in multiple sclerosis.
Neurodevelopmental Consequences Induced by Early-Life Lead Exposure Through Disruption of Neurotransmitter Pathways and Molecular Mechanisms: A Systematic Review.
Satralizumab in the management of aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder during pregnancy: a case report.
Immersive Technologies of Virtual and Augmented Reality (VR/AR) in Patient-Centered Neurorehabilitation.
Inhibition of Lin-11, Isl-1, and Mec‑3 Kinase (LIMK) Activity Attenuates Astrogliosis and Vascular Remodeling in an Experimental Model of Cuprizone-Induced Demyelination in Mice.
Anti-CD20 Therapies in Pediatric Acquired Demyelinating Syndromes: Evidence Across MS, AQP4-IgG-Positive NMOSD and MOGAD.
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
RETRACTION: Automatic Intelligent System Using Medical of Things for Multiple Sclerosis Detection.
Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.
Pages
« first
‹ previous
…
1051
1052
1053
1054
1055
1056
1057
1058
1059
…
next ›
last »